Two U.S. fund filings submitted to the Securities and Exchange Commission on Aug. 27 and Aug. 28 listed three XRP-linked exchange-traded funds, signaling expanding use of the token in regulated investment products. The filings do not represent SEC approval of new products. They follow seven spot XRP ETFs that had attracted $1.57 billion in cumulative inflows by Aug. 24, led by Bitwise, Canary Capital and Franklin Templeton. ProShares’ filing includes an unlevered XRP ETF, series S000091571, and a 2x leveraged Ultra XRP ETF, series S000091573, ticker UXRP. The leveraged fund seeks twice the daily return of the Bloomberg XRP Index and uses futures and swaps to achieve its target. Its assets under management were reported between $40 million and $55 million, with a net asset value near $15.83 after a recent decline. The unlevered ProShares XRP ETF appears in the trust filing but remains listed as pending on tracking services, indicating that shares may not yet be tradable through U.S. brokerage accounts. Morningstar Funds Trust filed a post-effective amendment on Aug. 28 that added the Cyber Hornet S&P 500 and XRP 75/25 Strategy ETF, ticker XXX. The fund combines about 75% S&P 500 equities with roughly 25% XRP exposure, holds stocks such as Nvidia, Apple, Microsoft and Amazon, and reported a net asset value of $22.08 with assets near $550,000. Spot XRP ETFs collectively held about 1.5% of XRP’s supply, and trading volume reached a record $125 million on Aug. 20. Goldman Sachs disclosed $86.5 million of exposure across five spot XRP ETFs in its Q2 regulatory filing. Ripple is scheduled to release 1 billion XRP from escrow on Sept. 1, and the Senate will consider cloture on the Digital Asset Market Clarity Act on Sept. 15, a vote that will determine whether debate proceeds. The filings do not constitute SEC approval, and the outcome of the Senate vote on the Digital Asset Market Clarity Act remains uncertain, which could influence future demand for XRP investment products.